Local Institution

Hartford, Connecticut 06106

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Hodgkin Disease Clinical Trial
A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Hartford, CT
Click here to add this to my saved trials